Patients are injecting peptides: Ask before you operate
A patient on next week’s surgical schedule is likely to be injecting a compound that no regulator has approved; no randomized trial has tested in human tendons, ligaments or bone; and no pharmacy has yet been authorized to compound.
Chances are the patient has not told you or your staff. In a review of clinical notes from more than 15 million patients across a national health-record network, Venkatakrishnan and colleagues identified 1,039 confirmed users of BPC-157, which is half of the “Wolverine stack” that pairs with TB-500. New users have increased 33-fold between 2020